bluebird bio IncNASDAQ:BLUENASDAQ FSI:E. Delinquent (Issuer missed regulatory filing deadline)
- LAST PRICE1.0300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0400/ 67
- Ask / Lots1.0600/ 90
- Open / Previous Close1.0400 / 1.0300
- Day Range
- 52 Week Range
- Volume2,208,868
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLUE |
|---|---|---|
| 09:32 ET | 21750 | 1.045 |
| 09:34 ET | 23082 | 1.045 |
| 09:36 ET | 28552 | 1.03 |
| 09:38 ET | 38007 | 1.0397 |
| 09:39 ET | 7031 | 1.03 |
| 09:41 ET | 2900 | 1.035 |
| 09:43 ET | 18517 | 1.04 |
| 09:45 ET | 29870 | 1.045 |
| 09:48 ET | 6548 | 1.05 |
| 09:50 ET | 5925 | 1.06 |
| 09:52 ET | 14400 | 1.0597 |
| 09:54 ET | 12749 | 1.05 |
| 09:56 ET | 15560 | 1.05 |
| 09:57 ET | 31859 | 1.05 |
| 09:59 ET | 17573 | 1.05 |
| 10:01 ET | 5511 | 1.05 |
| 10:03 ET | 10197 | 1.055 |
| 10:06 ET | 106206 | 1.065 |
| 10:08 ET | 7720 | 1.07 |
| 10:10 ET | 40718 | 1.0615 |
| 10:12 ET | 2708 | 1.065 |
| 10:14 ET | 16563 | 1.065 |
| 10:15 ET | 3830 | 1.07 |
| 10:17 ET | 64956 | 1.0521 |
| 10:19 ET | 18682 | 1.055 |
| 10:21 ET | 50491 | 1.06 |
| 10:24 ET | 15880 | 1.06 |
| 10:26 ET | 7233 | 1.06 |
| 10:28 ET | 30818 | 1.06 |
| 10:30 ET | 6982 | 1.065 |
| 10:32 ET | 2200 | 1.065 |
| 10:33 ET | 7250 | 1.065 |
| 10:35 ET | 14226 | 1.065 |
| 10:37 ET | 31353 | 1.0601 |
| 10:39 ET | 2894 | 1.065 |
| 10:42 ET | 7283 | 1.065 |
| 10:44 ET | 136 | 1.065 |
| 10:46 ET | 1710 | 1.065 |
| 10:48 ET | 500 | 1.0601 |
| 10:50 ET | 22150 | 1.0649 |
| 10:51 ET | 28989 | 1.06 |
| 10:53 ET | 3093 | 1.065 |
| 10:55 ET | 2055 | 1.06 |
| 10:57 ET | 12317 | 1.065 |
| 11:00 ET | 32952 | 1.055 |
| 11:04 ET | 100 | 1.055 |
| 11:06 ET | 456 | 1.05 |
| 11:08 ET | 1510 | 1.0557 |
| 11:09 ET | 990 | 1.05 |
| 11:11 ET | 15889 | 1.045 |
| 11:13 ET | 6780 | 1.04 |
| 11:15 ET | 1983 | 1.04 |
| 11:18 ET | 13826 | 1.04 |
| 11:20 ET | 2121 | 1.045 |
| 11:22 ET | 700 | 1.045 |
| 11:24 ET | 100 | 1.04 |
| 11:26 ET | 8838 | 1.0496 |
| 11:27 ET | 300 | 1.04 |
| 11:29 ET | 1229 | 1.045 |
| 11:31 ET | 2257 | 1.045 |
| 11:33 ET | 3556 | 1.0449 |
| 11:36 ET | 655 | 1.04 |
| 11:38 ET | 42293 | 1.04 |
| 11:40 ET | 4314 | 1.04 |
| 11:42 ET | 2000 | 1.04 |
| 11:44 ET | 517 | 1.04 |
| 11:45 ET | 16553 | 1.045 |
| 11:47 ET | 2831 | 1.045 |
| 11:49 ET | 11316 | 1.045 |
| 11:54 ET | 3384 | 1.047 |
| 11:56 ET | 12330 | 1.04 |
| 11:58 ET | 2311 | 1.04 |
| 12:00 ET | 1055 | 1.045 |
| 12:02 ET | 1371 | 1.04 |
| 12:03 ET | 628 | 1.04 |
| 12:05 ET | 1117 | 1.045 |
| 12:07 ET | 10928 | 1.04 |
| 12:09 ET | 1770 | 1.045 |
| 12:12 ET | 200 | 1.0421 |
| 12:14 ET | 1730 | 1.045 |
| 12:16 ET | 1014 | 1.045 |
| 12:18 ET | 1517 | 1.04 |
| 12:20 ET | 1692 | 1.045 |
| 12:21 ET | 916 | 1.0414 |
| 12:23 ET | 6537 | 1.04 |
| 12:25 ET | 2431 | 1.045 |
| 12:27 ET | 3939 | 1.045 |
| 12:30 ET | 1309 | 1.045 |
| 12:32 ET | 1000 | 1.045 |
| 12:34 ET | 3209 | 1.0496 |
| 12:36 ET | 3279 | 1.04 |
| 12:39 ET | 27602 | 1.045 |
| 12:41 ET | 13113 | 1.05 |
| 12:43 ET | 14250 | 1.06 |
| 12:45 ET | 1138 | 1.055 |
| 12:48 ET | 1313 | 1.055 |
| 12:50 ET | 265 | 1.055 |
| 12:52 ET | 13328 | 1.055 |
| 12:54 ET | 600 | 1.05 |
| 12:56 ET | 30976 | 1.0599 |
| 12:57 ET | 3600 | 1.05 |
| 12:59 ET | 1090 | 1.055 |
| 01:01 ET | 413 | 1.055 |
| 01:03 ET | 300 | 1.05 |
| 01:06 ET | 800 | 1.0541 |
| 01:08 ET | 300 | 1.06 |
| 01:10 ET | 1317 | 1.05 |
| 01:12 ET | 700 | 1.052 |
| 01:14 ET | 300 | 1.055 |
| 01:15 ET | 612 | 1.055 |
| 01:17 ET | 1249 | 1.05 |
| 01:19 ET | 391 | 1.055 |
| 01:21 ET | 800 | 1.05 |
| 01:24 ET | 500 | 1.05 |
| 01:26 ET | 1264 | 1.05 |
| 01:28 ET | 700 | 1.05 |
| 01:30 ET | 4869 | 1.055 |
| 01:32 ET | 1174 | 1.055 |
| 01:33 ET | 400 | 1.05 |
| 01:35 ET | 4777 | 1.05 |
| 01:37 ET | 500 | 1.05 |
| 01:39 ET | 766 | 1.05 |
| 01:42 ET | 100 | 1.05 |
| 01:44 ET | 4297 | 1.05 |
| 01:46 ET | 399 | 1.05 |
| 01:48 ET | 500 | 1.05 |
| 01:50 ET | 500 | 1.05 |
| 01:51 ET | 612 | 1.0501 |
| 01:53 ET | 641 | 1.05 |
| 01:55 ET | 2985 | 1.055 |
| 01:57 ET | 400 | 1.05 |
| 02:00 ET | 21752 | 1.0503 |
| 02:02 ET | 1511 | 1.05 |
| 02:04 ET | 5200 | 1.05 |
| 02:06 ET | 2500 | 1.055 |
| 02:08 ET | 304 | 1.05 |
| 02:09 ET | 17025 | 1.0509 |
| 02:11 ET | 28023 | 1.04 |
| 02:13 ET | 1901 | 1.04 |
| 02:15 ET | 5860 | 1.0401 |
| 02:18 ET | 1800 | 1.04 |
| 02:20 ET | 1400 | 1.045 |
| 02:22 ET | 3708 | 1.04 |
| 02:24 ET | 4411 | 1.045 |
| 02:26 ET | 6000 | 1.045 |
| 02:27 ET | 87410 | 1.0314 |
| 02:29 ET | 31058 | 1.0499 |
| 02:31 ET | 10100 | 1.045 |
| 02:33 ET | 34000 | 1.05 |
| 02:36 ET | 141182 | 1.04 |
| 02:38 ET | 40891 | 1.04 |
| 02:40 ET | 9802 | 1.04 |
| 02:42 ET | 3843 | 1.045 |
| 02:44 ET | 2500 | 1.04 |
| 02:45 ET | 5084 | 1.04 |
| 02:47 ET | 12833 | 1.04 |
| 02:49 ET | 358 | 1.045 |
| 02:51 ET | 300 | 1.04 |
| 02:54 ET | 400 | 1.04 |
| 02:56 ET | 1001 | 1.0442 |
| 02:58 ET | 600 | 1.04 |
| 03:00 ET | 17000 | 1.035 |
| 03:02 ET | 7824 | 1.035 |
| 03:03 ET | 30285 | 1.04 |
| 03:05 ET | 616 | 1.0411 |
| 03:07 ET | 23196 | 1.03 |
| 03:09 ET | 20065 | 1.04 |
| 03:12 ET | 14196 | 1.0411 |
| 03:14 ET | 200 | 1.04 |
| 03:16 ET | 2759 | 1.045 |
| 03:18 ET | 12656 | 1.04 |
| 03:20 ET | 1333 | 1.045 |
| 03:21 ET | 22493 | 1.035 |
| 03:23 ET | 1383 | 1.03 |
| 03:25 ET | 6241 | 1.035 |
| 03:27 ET | 11668 | 1.03 |
| 03:30 ET | 1190 | 1.035 |
| 03:32 ET | 3456 | 1.03 |
| 03:34 ET | 3063 | 1.04 |
| 03:36 ET | 2676 | 1.04 |
| 03:38 ET | 7342 | 1.04 |
| 03:39 ET | 4514 | 1.035 |
| 03:41 ET | 19754 | 1.03 |
| 03:43 ET | 4090 | 1.03 |
| 03:45 ET | 3498 | 1.04 |
| 03:48 ET | 4750 | 1.03 |
| 03:50 ET | 6016 | 1.03 |
| 03:52 ET | 19779 | 1.035 |
| 03:54 ET | 4120 | 1.04 |
| 03:56 ET | 7914 | 1.04 |
| 03:57 ET | 23105 | 1.04 |
| 03:59 ET | 51722 | 1.03 |
Today
Investors who lost money on bluebird bio, Inc.(BLUE) should contact Levi & Korsinsky about pending Class Action - BLUE, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesInvestors who lost money on bluebird bio, Inc.(BLUE) should contact Levi & Korsinsky about pending Class Action - BLUE, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesUPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesDEADLINE ALERT for EVLV, BLUE, and LUNA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders, from 5 hours ago by Dow Jones
5 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
bluebird bio Inc | 196.1M | -1.4x | --- |
Abeona Therapeutics Inc | 181.2M | -1.4x | --- |
Atossa Therapeutics Inc | 196.7M | -6.8x | --- |
Trevi Therapeutics Inc | 195.1M | -8.4x | --- |
Elevation Oncology Inc | 197.2M | -3.6x | --- |
CervoMed Inc | 198.8M | 38.6x | --- |
Company Information
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. It has two gene therapies: ZYNTEGLO (betibeglogene autotemcel) and SKYSONA (elivaldogene autotemcel). ZYNTEGLO is the first gene therapy for people with B-thalassemia who require regular red blood cell transfusions. SKYSONA (elivaldogene autotemcel), also known as eli-cel, is used to slow the progression of eurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). It is also developing (lovotibeglogene autotemcel), also known as lovo-cel, as a one-time treatment for patients with sickle cell disease (SCD).
Contact Information
- Headquarters
- 455 Grand Union BoulevardSOMERVILLE, MA, United States 02145
- Phone
- 339-499-9300
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Mark Vachon
- President, Chief Executive Officer, Director
- Andrew Obenshain
- Chief Financial Officer
- Christopher Krawtschuk
- Chief Commercial and Operating Officer
- Thomas Klima
- Chief Medical Officer
- Richard Colvin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $196.1M |
|---|---|
Revenue (TTM) | $21.7M |
Shares Outstanding | 190.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.86 |
EPS | $-0.74 |
Book Value | $2.37 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 9.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -626.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
